
U.S. FDA inspection at Glenmark Pharma's Facility at Monroe, North Carolina, USA
The United States Food & Drug Administration (USFDA) conducted a GMP inspection at the Company's manufacturing facility situated in Monroe, North Carolina, USA from 09 June 2025 to 17 June 2025. At the end of the inspection, the Company was issued …